NDC 72934-1050

CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%

Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05%

CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Tazarotene; Niacinamide; Clindamycin Phosphate.

• Product ID: 72934-1050_8878edb5-6d17-5633-e053-2995a90a1486
• NDC: 72934-1050
• Product Type: Human Prescription Drug
• Proprietary Name: CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%
• Generic Name: Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05%
• Dosage Form: Gel
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-05-10
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sincerus Florida, LLC
• Substance Name: TAZAROTENE; NIACINAMIDE; CLINDAMYCIN PHOSPHATE
• Active Ingredient Strength: 0 g/100g; g/100g; g/100g
• Pharm Classes: Retinoid [EPC],Retinoids [CS],Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72934-1050-2

30 g in 1 BOTTLE, PUMP (72934-1050-2)

• Marketing Start Date: 2019-05-10
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72934-1050-2 [72934105002]

CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% GEL

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-05-10

Drug Details

Active Ingredients

Ingredient	Strength
TAZAROTENE	.05 g/100g

Pharmacological Class

• Retinoid [EPC]
• Retinoids [CS]
• Decreased Sebaceous Gland Activity [PE]
• Lincosamide Antibacterial [EPC]
• Lincosamides [CS]
• Retinoid [EPC]
• Retinoids [CS]
• Decreased Sebaceous Gland Activity [PE]
• Lincosamide Antibacterial [EPC]
• Lincosamides [CS]